Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials
Authors
Keywords
Cannabinoids, Chronic non-cancer pain, Neuropathic pain, Systematic review, Marijuana
Journal
Journal of Neuroimmune Pharmacology
Volume 10, Issue 2, Pages 293-301
Publisher
Springer Nature
Online
2015-03-21
DOI
10.1007/s11481-015-9600-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Need for a Canadian Pain Strategy
- (2016) Mary E Lynch Pain Research & Management
- A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment
- (2014) M. Serpell et al. EUROPEAN JOURNAL OF PAIN
- A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
- (2013) Mary E. Lynch et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
- (2012) J. Corey-Bloom et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
- (2012) Luigi Alberto Pini et al. JOURNAL OF HEADACHE AND PAIN
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- (2012) R. M. Langford et al. JOURNAL OF NEUROLOGY
- MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
- (2012) John Peter Zajicek et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
- (2012) Barth Wilsey et al. JOURNAL OF PAIN
- An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
- (2012) Cory Toth et al. PAIN
- An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
- (2012) John P. Huggins et al. PAIN
- Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
- (2012) R. G. Pertwee PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Endocannabinoids in nervous system health and disease: the big picture in a nutshell
- (2012) S. D. Skaper et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
- (2011) Mary E. Lynch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
- (2010) Mark A. Ware et al. ANESTHESIA AND ANALGESIA
- The evidence for pharmacological treatment of neuropathic pain
- (2010) Nanna Brix Finnerup et al. PAIN
- Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis
- (2010) Niklas Schuelert et al. PAIN
- The Pharmacotherapy of Chronic Pain
- (2008) Mary E. Lynch RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started